308 related articles for article (PubMed ID: 29049611)
1. Association of a Prophylactic Surgical Approach to Stage IV Small Intestinal Neuroendocrine Tumors With Survival.
Daskalakis K; Karakatsanis A; Hessman O; Stuart HC; Welin S; Tiensuu Janson E; Öberg K; Hellman P; Norlén O; Stålberg P
JAMA Oncol; 2018 Feb; 4(2):183-189. PubMed ID: 29049611
[TBL] [Abstract][Full Text] [Related]
2. Upfront surgery of small intestinal neuroendocrine tumors. Time to reconsider?
Daskalakis K; Tsolakis AV
World J Gastroenterol; 2018 Aug; 24(29):3201-3203. PubMed ID: 30090001
[TBL] [Abstract][Full Text] [Related]
3. Association of lymph node metastases, grade and extent of mesenteric lymph node dissection in locoregional small intestinal neuroendocrine tumors with recurrence-free survival.
Daskalakis K; Wedin M; Tsoli M; Kogut A; Srirajaskanthan R; Sarras K; Kattiparambil S; Giovos G; Weickert MO; Kos-Kudla B; Kaltsas G
J Neuroendocrinol; 2022 Nov; 34(11):e13205. PubMed ID: 36385444
[TBL] [Abstract][Full Text] [Related]
4. Relevant prognostic factors in patients with stage IV small intestine neuroendocrine neoplasms.
Maurer E; Heinzel-Gutenbrunner M; Rinke A; Rütz J; Holzer K; Figiel J; Luster M; Bartsch DK
J Neuroendocrinol; 2022 Jan; 34(1):e13076. PubMed ID: 34964186
[TBL] [Abstract][Full Text] [Related]
5. Long-term results of surgery for small intestinal neuroendocrine tumors at a tertiary referral center.
Norlén O; Stålberg P; Öberg K; Eriksson J; Hedberg J; Hessman O; Janson ET; Hellman P; Åkerström G
World J Surg; 2012 Jun; 36(6):1419-31. PubMed ID: 21984144
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Role of Lymph Node Positivity and Number of Lymph Nodes Needed for Accurately Staging Small-Bowel Neuroendocrine Tumors.
Zaidi MY; Lopez-Aguiar AG; Dillhoff M; Beal E; Poultsides G; Makris E; Rocha F; Crown A; Idrees K; Marincola Smith P; Nathan H; Beems M; Abbott D; Barrett JR; Fields RC; Davidson J; Cardona K; Maithel SK
JAMA Surg; 2019 Feb; 154(2):134-140. PubMed ID: 30383112
[TBL] [Abstract][Full Text] [Related]
7. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.
Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT
Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744
[TBL] [Abstract][Full Text] [Related]
8. Indication for liver transplantation in young patients with small intestinal NETs is rare?
Norlén O; Daskalakis K; Öberg K; Åkerström G; Stålberg P; Hellman P
World J Surg; 2014 Mar; 38(3):742-7. PubMed ID: 24233660
[TBL] [Abstract][Full Text] [Related]
9. Surgical treatment of neuroendocrine tumors in the second portion of the duodenum: a single center experience and systematic review of the literature.
Iwasaki T; Nara S; Kishi Y; Esaki M; Shimada K; Hiraoka N
Langenbecks Arch Surg; 2017 Sep; 402(6):925-933. PubMed ID: 27915372
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of Cytoreductive Surgery for Metastatic Low-Grade Neuroendocrine Tumors in the Setting of Extrahepatic Metastases.
Chan DL; Dixon M; Law CHL; Koujanian S; Beyfuss KA; Singh S; Myrehaug S; Hallet J
Ann Surg Oncol; 2018 Jun; 25(6):1768-1774. PubMed ID: 29560571
[TBL] [Abstract][Full Text] [Related]
11. Epidemiologic Trends of and Factors Associated With Overall Survival for Patients With Gastroenteropancreatic Neuroendocrine Tumors in the United States.
Xu Z; Wang L; Dai S; Chen M; Li F; Sun J; Luo F
JAMA Netw Open; 2021 Sep; 4(9):e2124750. PubMed ID: 34554237
[TBL] [Abstract][Full Text] [Related]
12. Survival and disease recurrence in patients operated for small intestinal neuroendocrine tumors at a referral hospital.
Folkestad O; Wasmuth HH; Mjønes P; Fougner R; Hauso Ø; Fossmark R
Surg Oncol; 2020 Dec; 35():336-343. PubMed ID: 32979699
[TBL] [Abstract][Full Text] [Related]
13. Surgical Management of Small Bowel Neuroendocrine Tumors: Specific Requirements and Their Impact on Staging and Prognosis.
Pasquer A; Walter T; Hervieu V; Forestier J; Scoazec JY; Lombard-Bohas C; Poncet G
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S742-9. PubMed ID: 26014153
[TBL] [Abstract][Full Text] [Related]
14. Resection of primary tumor may prolong survival in metastatic gastroenteropancreatic neuroendocrine tumors.
Tierney JF; Chivukula SV; Wang X; Pappas SG; Schadde E; Hertl M; Poirier J; Keutgen XM
Surgery; 2019 Mar; 165(3):644-651. PubMed ID: 30366604
[TBL] [Abstract][Full Text] [Related]
15. Clinical signs of fibrosis in small intestinal neuroendocrine tumours.
Daskalakis K; Karakatsanis A; Stålberg P; Norlén O; Hellman P
Br J Surg; 2017 Jan; 104(1):69-75. PubMed ID: 27861745
[TBL] [Abstract][Full Text] [Related]
16. Extent of Lymph Node Dissection for Small Bowel Neuroendocrine Tumors.
Hallet J; Law C;
World J Surg; 2021 Jan; 45(1):197-202. PubMed ID: 32737557
[TBL] [Abstract][Full Text] [Related]
17. Revised staging classification improves outcome prediction for small intestinal neuroendocrine tumors.
Kim MK; Warner RR; Roayaie S; Harpaz N; Ward SC; Itzkowitz S; Wisnivesky JP
J Clin Oncol; 2013 Oct; 31(30):3776-81. PubMed ID: 24043726
[TBL] [Abstract][Full Text] [Related]
18. Surgery of the primary tumour in 201 patients with high-grade gastroenteropancreatic neuroendocrine and mixed neuroendocrine-non-neuroendocrine neoplasms.
Pommergaard HC; Nielsen K; Sorbye H; Federspiel B; Tabaksblat EM; Vestermark LW; Janson ET; Hansen CP; Ladekarl M; Garresori H; Hjortland GO; Sundlöv A; Galleberg R; Knigge P; Kjaer A; Langer SW; Knigge U
J Neuroendocrinol; 2021 May; 33(5):e12967. PubMed ID: 33769624
[TBL] [Abstract][Full Text] [Related]
19. Survival effects of primary and metastatic surgical treatment in metastatic small intestinal tumors: A propensity score-matching study.
Zhou Z; Ge H; Li Y; Wang D; Güngör C
PLoS One; 2022; 17(6):e0270608. PubMed ID: 35749551
[TBL] [Abstract][Full Text] [Related]
20. Surgical Principles in the Management of Small Bowel Neuroendocrine Tumors.
Gangi A; Anaya DA
Curr Treat Options Oncol; 2020 Aug; 21(11):88. PubMed ID: 32862334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]